Brevan Howard Capital Management LP
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1512857
ST. HELIER, Y9
Position in AKBA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$72,675
+$36,506 QoQ
Shares Held
63,750
+145.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 170 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $20,713,489 across 26 Drug Manufacturers - Specialty & Generic names. AKBA ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
231,624 | $3,678,189 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,174 | $2,261,598 | |
| 3 | ZTS |
Zoetis Inc.
|
26,423 | $1,898,755 | |
| 4 | LQDA |
Liquidia Corp
|
20,664 | $1,647,540 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
14,589 | $1,618,503 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
85,545 | $1,480,783 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,148 | $1,322,591 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
96,574 | $965,740 |
All Filings in AKBA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,675 | 63,750 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $36,169 | 26,021 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $380,975 | 236,631 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $213,270 | 78,121 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $62,418 | 17,148 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $149,467 | 81,676 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||